# Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer

> **NCT00068549** · PHASE1 · COMPLETED · sponsor: **Gynecologic Oncology Group** · enrollment: 13 (actual)

## Conditions studied

- Cervical Adenocarcinoma
- Cervical Adenosquamous Carcinoma
- Cervical Small Cell Carcinoma
- Cervical Squamous Cell Carcinoma
- Stage IB Cervical Cancer
- Stage IIA Cervical Cancer
- Stage IIB Cervical Cancer
- Stage III Cervical Cancer
- Stage IVA Cervical Cancer

## Interventions

- **DRUG:** Gemcitabine Hydrochloride
- **DRUG:** Cisplatin
- **RADIATION:** Radiation Therapy
- **RADIATION:** Internal Radiation Therapy

## Key facts

- **NCT ID:** NCT00068549
- **Lead sponsor:** Gynecologic Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** 2008-01
- **Final completion:** —
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2014-12-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00068549

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00068549, "Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00068549. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*